CLINICAL_TRIALS
trial_result
· 2017-04-14
Clinical Trial Update: Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine [Phase 1]
Summary
Phase 1 safety and immunogenicity study of a dengue virus DNA vaccine completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 1 | Status: COMPLETED | Results posted: 2017-04-14